KactusBio

KactusBio is an R&D-driven, innovative biotech company dedicated to drug discovery, immunotherapy, and mRNA vaccines. Established in March 2018, KactusBio's growth has outpaced the industry, setting itself apart through a commitment to advancing healthcare solutions. The company has developed strategic partnerships with more than 300 organisations, emphasizing innovative antibody-drug discovery, cell and gene therapy, and mRNA vaccine development.

Services include:
- Drug discovery
- Immunotherapy
- mRNA vaccine development
- Antibody-drug conjugate discovery
- Cell and gene therapy
- Contract manufacturing (CMO/CDMO)

KactusBio continues to be a significant supplier to the pharmaceutical industry, driving the future of biopharmaceutical innovation. For more information, visit kactusbio.com.